Can nanopore technology help in curing cancer at molecular level?
Nanopore sequencing can detect large deletions, translocations and inversions at dilutions as low with few reads per sample. Given the speed, small footprint, and low capital cost, nanopore sequencing could become the ideal tool for the low-level detection of cancer-associated structural variations needed for molecular relapse, early detection, or therapeutic monitoring.
Comments
Leave a comment